Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.
The 52 Week Low is $56.56 set on Wed, Dec 30, 2020. The current price, $71.69, is 27% above the 52 Week Low.
The 52 Week High is $73.09 set on Tue, Aug 17, 2021.
The All-Time High is $122.40 set on Tue, Jun 23, 2015. The current price, $71.69, is 41% below the All Time High.
Gilead Sciences trades on the NASDAQ. GILD's market cap is 89.5 Billion.
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. The acquisitions of Corus Pharma, Myogen, CV Therapeutics, Arresto Biosciences, and Calistoga have broadened this focus to include pulmonary and cardiovascular diseases and cancer. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of combination drug Harvoni, and the Kite, Forty Seven, and Immunomedics acquisitions boost Gilead's exposure to cell therapy and noncell therapy in oncology.